Navigation Links
National Institute of Advanced Industrial Science and Technology (AIST) Adopts ChemAxon JChem Base for Japanese Consortium for Glycobiology and Glycotechnology Database (JCGGDB)

National Institute of Advanced Industrial Science and Technology (AIST) Adopts... -- TOKYO and BUDAPEST, Hungary, November 2, 2010 /PRNewswire/ --

Advanced Search Search

  1. Send a release
  2. Member sign in
  3. Become a member
  4. For journalists
  5. Global sites
PR Newswire: news distribution, targeting and monitoring
  1. Products & Services
  2. Knowledge Center
  3. Browse News Releases
  4. Contact PR Newswire
Computer Software, Biotechnology, Health Care & Hospitals, Pharmaceuticals, Chemical, Networks, Licensing, New Products & Services Click to view news release full screen  

National Institute of Advanced Industrial Science and Technology (AIST) Adopts ChemAxon JChem Base for Japanese Consortium for Glycobiology and Glycotechnology Database (JCGGDB)


TOKYO and BUDAPEST, Hungary, November 2, 2010 /PRNewswire/ -- Patcore Inc. and ChemAxon, a leading provider of cheminformatics software for the life sciences industry, announce the licensing of ChemAxon's JChem for the Japanese Consortium for Glycobiology and Glycotechnology Database (JCGGDB: ). Currently there is an ongoing project, called "Life Science Integrated Database Project" (LSDB : ), led by the Japanese government and The National Institute of Advanced Industrial Science and Technology (AIST) has taken the lead in the glycoscience part of this project. AIST have been consolidating glycoscience-related databases within the country and building the integrated one. The ChemAxon's JChem software is to be used to enable the integrated chemical structure search in JCGGDB.

JChem Base is a tool for the development of cheminformatics applications allowing storage and search of structural and non-structural data. JChem Base can handle molecules, reactions, polymers, Markush and query structural contents. JChem Base will integrate a variety of database systems with web interfaces and offer high performance searches including substructure, similarity, exact, and superstructure searches. The system includes Marvin, a family of toolkits and graphic user interfaces for editing, viewing and visualizing chemical structures and macromolecules.

"We are honored to work with AIST in this ground breaking project, we expect the full potential of our functionality to bring new possibilities and value to users," said Alex Drijver, CEO of ChemAxon.

"We are very pleased for the JChem technology to be adopted for the portal of glycotechnology," added Fumiaki Aruga, COO of Patcore, ChemAxon's exclusive commercial agent in Japan.

About AIST

AIST has over 50 autonomous research units in various innovative research fields, and the units are located at 9 research bases and several sites of AIST all over Japan. Missions of AIST are as follows, and AIST members are making efforts to accomplish the missions.

- Contribution to a sustainable society. - Contribution to industrial competitiveness. - Contribution to local industrial development. - Contribution to industrial technology policies.

About ChemAxon

ChemAxon is a leader in providing cheminformatics software development platforms and applications for the biotechnology, pharmaceutical and agrochemical industries. With core capabilities for structure visualization, search and management, property prediction, virtual synthesis, screening and drug design, ChemAxon focuses upon active interaction with users and software portability to create powerful, cost effective cross platform solutions and programming interfaces to power modern cheminformatics and chemical communication. For more information please visit

About Patcore

Patcore Inc. is a Japan-based informatics services company for life science research. The company provides cheminformatics products and services to enable its customers to accelerate their research and discover new products faster. With extensive knowledge of informatics strategy and research processes, Patcore facilitates better decision making for pharmaceutical, biotechnology, agrochemical, and chemical researchers.

SOURCE ChemAxon Ltd.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Vicus Therapeutics to Present at the 234th American Chemical Society National Meeting in Boston, MA
2. National Stem Cell Holding, Inc. Discovers Non-Embryonic Biomaterials that Promote Tissue Repair
3. Intellect Neurosciences, Inc. to Present Data on Alzheimers Vaccine at 13th International Congress of Immunology Conference
4. Paper in International Journal of Oncology Reports Alfacells ONCONASE(R) Suppresses Intracellular Oxidative Stress
5. Ozarelix Phase 2 Data Presented at 29th Congress of the Societe Internationale dUrologie
6. Anadys Pharmaceuticals Presents Preclinical Results on ANA598, a Non-Nucleoside Inhibitor of the NS5B Polymerase, at the 14th International Symposium on Hepatitis C Virus and Related Viruses
7. Public Forum to Discuss Addiction as a Treatable Disease and Highlight National Alcohol and Drug Addiction Recovery Month
8. K-State Researchers Bringing Expertise to Kansas City Symposium on Disease and National Security
9. International Expert Group Initiates Largest Multi-center Phase III Trial to Evaluate NeuroAid(TM) in Stroke Recovery
10. September is National Pain Awareness Month
11. Virogenomics, Inc. Awarded $2 Million National Institute of Standards and Technology (NIST) Advanced Technology Program Grant to Develop Integrated Diagnostic Biosensors
Post Your Comments:
(Date:12/1/2015)... BANGALORE, India and ... (NASDAQ, TASE: MYL) today announced that it expects to ... for developing country markets funded by international donors, TLE400 ... + Efavirenz 400 mg) for $99 per patient, per ... (CHAI) to develop TLE400. The significantly reduced price could ...
(Date:12/1/2015)... , Dec. 1, 2015 Breg, Inc ... services, announced today that it has been awarded three ... Members served by Novation will have access to improved ... bracing products and soft goods dedicated to advancing orthopedic ... The aging U.S. population, rising prevalence of chronic ...
(Date:12/1/2015)... , Dec. 1, 2015 Building ... HIV/AIDS, Johnson & Johnson (NYSE: JNJ ) ... Janssen Pharmaceutical Companies to significantly reduce the burden ... make up 74 percent of new HIV infections ... on World AIDS Day, these new initiatives include ...
Breaking Medicine Technology:
(Date:12/1/2015)... ... December 01, 2015 , ... SAN FRANCISCO, ... announced that the organization has awarded Education and Developmental Therapies (EDT), an Applied ... The award celebrates exceptional special needs providers that excel in synthesizing the areas ...
(Date:12/1/2015)... ... ... Lutronic, a leading innovator of aesthetic and medical laser and energy-based technology, announced ... the United States. Clarity is a Superior Dual Wavelength Platform which combines two ... platform that is easy to own and operate. , For over a decade, ...
(Date:12/1/2015)... , ... December 01, 2015 , ... XTC Semifinals ... 10 semi-finalists to head to Las Vegas for CES 2016, the world’s largest Consumer ... of Consumer Technology Association Gary Shapiro, Founding Partner of Pacific Investments Veronica Serra, and ...
(Date:12/1/2015)... (PRWEB) , ... December 01, 2015 , ... Nurotron Biotechnology ... in its largest order to date. , The order will be from the ... Nurotron’s Venus Cochlear Implant System is an effective solution for children and adults suffering ...
(Date:12/1/2015)... (PRWEB) , ... December 01, 2015 , ... ... Contact Center Enterprise Authorized Technology Provider (ATP) status from Cisco. This designation recognizes ... and support Cisco Unified Contact Center solutions targeted to the high-end enterprise contact ...
Breaking Medicine News(10 mins):